Loading...
Keywords
Last Name
Institution

Rangaraj Selvarangan

Concepts (477)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Influenza, Human
17
2022
34
7.830
Why?
Parechovirus
14
2021
17
7.110
Why?
Enterovirus Infections
16
2022
29
6.960
Why?
Picornaviridae Infections
13
2021
18
6.780
Why?
Respiratory Tract Infections
16
2022
57
6.240
Why?
Molecular Diagnostic Techniques
13
2021
36
6.060
Why?
Influenza A virus
10
2020
18
5.870
Why?
Infant
77
2022
1388
5.270
Why?
Influenza B virus
10
2021
16
5.120
Why?
Humans
131
2022
5931
5.100
Why?
Child, Preschool
69
2022
1492
4.390
Why?
Child
80
2022
2792
4.370
Why?
Respiratory Syncytial Virus Infections
9
2020
37
4.160
Why?
Nucleic Acid Amplification Techniques
6
2020
12
4.140
Why?
Enterovirus D, Human
11
2022
21
3.810
Why?
Enterovirus
6
2021
8
3.720
Why?
Sensitivity and Specificity
28
2021
145
3.430
Why?
Anti-Bacterial Agents
17
2021
232
3.290
Why?
Gastroenteritis
13
2021
20
3.260
Why?
Female
71
2021
3348
3.140
Why?
Respiratory Syncytial Virus, Human
5
2019
18
3.140
Why?
Male
66
2021
3276
3.050
Why?
Disease Outbreaks
10
2022
23
2.920
Why?
Adolescent
44
2021
1960
2.730
Why?
Central Nervous System Infections
3
2021
5
2.710
Why?
Diagnostic Tests, Routine
5
2019
19
2.640
Why?
Real-Time Polymerase Chain Reaction
8
2020
33
2.610
Why?
Infant, Newborn
33
2021
877
2.600
Why?
Nasopharynx
10
2021
23
2.330
Why?
United States
38
2022
624
2.290
Why?
Feces
15
2021
34
2.240
Why?
Bacteremia
5
2021
27
2.160
Why?
Streptococcal Infections
4
2020
20
2.130
Why?
Reverse Transcriptase Polymerase Chain Reaction
10
2020
87
2.010
Why?
Prospective Studies
19
2021
470
1.960
Why?
Reagent Kits, Diagnostic
9
2018
12
1.930
Why?
Antibodies, Viral
7
2022
29
1.930
Why?
Hospitalization
15
2021
169
1.840
Why?
Virology
5
2015
5
1.770
Why?
Urinary Tract Infections
3
2021
23
1.720
Why?
Rotavirus Vaccines
7
2019
9
1.670
Why?
Young Adult
18
2021
582
1.670
Why?
Polymerase Chain Reaction
7
2019
98
1.600
Why?
Bacteriological Techniques
5
2021
7
1.580
Why?
DNA, Viral
4
2020
13
1.570
Why?
Point-of-Care Testing
2
2020
7
1.560
Why?
Adult
22
2021
1096
1.550
Why?
Sepsis
4
2018
24
1.530
Why?
Rotavirus Infections
9
2021
10
1.530
Why?
Mycoplasma pneumoniae
5
2020
12
1.460
Why?
Pneumonia, Mycoplasma
5
2020
13
1.460
Why?
Middle Aged
16
2021
567
1.460
Why?
Aged
13
2021
306
1.440
Why?
Clostridium Infections
3
2020
7
1.410
Why?
Aged, 80 and over
10
2021
116
1.380
Why?
Retrospective Studies
18
2022
1148
1.360
Why?
Specimen Handling
5
2021
17
1.340
Why?
Staphylococcal Infections
4
2016
23
1.330
Why?
Staphylococcus aureus
3
2016
19
1.310
Why?
Emergency Service, Hospital
5
2021
139
1.300
Why?
Norovirus
4
2021
5
1.280
Why?
Respiratory System
3
2015
4
1.250
Why?
Cerebrospinal Fluid
4
2020
7
1.240
Why?
Immunoassay
4
2015
9
1.210
Why?
Hematopoietic Stem Cell Transplantation
3
2020
43
1.190
Why?
Point-of-Care Systems
3
2020
16
1.180
Why?
Genotype
16
2021
296
1.160
Why?
Bodily Secretions
2
2015
3
1.130
Why?
Caliciviridae Infections
3
2021
4
1.100
Why?
Antibodies, Neutralizing
4
2022
29
1.090
Why?
Streptococcus pyogenes
3
2020
14
1.080
Why?
Drug Resistance, Multiple, Bacterial
3
2021
11
1.080
Why?
Enterobacteriaceae
2
2021
5
1.080
Why?
Missouri
8
2022
90
1.070
Why?
Rhinovirus
2
2020
6
1.030
Why?
Vancomycin Resistance
2
2014
4
1.030
Why?
Escherichia coli
11
2017
33
1.010
Why?
Virus Diseases
2
2020
12
1.010
Why?
Inpatients
3
2020
49
0.980
Why?
Automation, Laboratory
2
2019
3
0.970
Why?
Rotavirus
6
2021
6
0.970
Why?
Population Surveillance
6
2021
15
0.960
Why?
Time Factors
9
2020
277
0.950
Why?
Pharyngitis
2
2020
14
0.940
Why?
Multiplex Polymerase Chain Reaction
2
2018
6
0.940
Why?
Cephalosporins
2
2021
16
0.930
Why?
Itraconazole
2
2020
2
0.920
Why?
Triazoles
2
2020
4
0.920
Why?
Clinical Laboratory Techniques
5
2021
9
0.900
Why?
Neurodevelopmental Disorders
1
2021
12
0.890
Why?
Influenza Vaccines
4
2021
12
0.890
Why?
Microbial Sensitivity Tests
12
2021
35
0.890
Why?
Mass Screening
2
2019
40
0.890
Why?
Bacterial Infections
1
2021
28
0.880
Why?
Phlebotomy
2
2011
3
0.870
Why?
Equipment Contamination
2
2011
6
0.870
Why?
Antiviral Agents
4
2021
22
0.860
Why?
Prevalence
11
2021
138
0.860
Why?
Enterocolitis, Pseudomembranous
1
2020
4
0.850
Why?
Asymptomatic Infections
1
2020
4
0.840
Why?
RNA Viruses
1
2019
3
0.820
Why?
Urinalysis
1
2019
7
0.810
Why?
Phylogeny
9
2021
18
0.800
Why?
Central Nervous System Viral Diseases
1
2019
3
0.790
Why?
Communicable Diseases, Emerging
1
2019
3
0.790
Why?
Antigens, Viral
3
2015
5
0.780
Why?
Peritonitis
2
2021
53
0.770
Why?
Drug Utilization
1
2018
16
0.750
Why?
Molecular Typing
1
2018
2
0.750
Why?
Respiratory Syncytial Viruses
2
2015
14
0.740
Why?
Bordetella Infections
2
2014
2
0.700
Why?
Bordetella parapertussis
2
2014
2
0.700
Why?
Peritoneal Dialysis
2
2021
148
0.700
Why?
Severity of Illness Index
6
2021
145
0.680
Why?
Escherichia coli Infections
7
2017
18
0.680
Why?
Influenza A Virus, H1N1 Subtype
3
2021
5
0.670
Why?
Carrier State
2
2018
5
0.670
Why?
Adhesins, Escherichia coli
9
2017
9
0.660
Why?
Methicillin-Resistant Staphylococcus aureus
5
2016
16
0.640
Why?
Fever
4
2021
33
0.630
Why?
Venous Thromboembolism
1
2015
11
0.610
Why?
Drug Resistance, Bacterial
5
2020
15
0.610
Why?
Sequence Analysis, DNA
7
2019
102
0.610
Why?
Herpes Simplex
2
2020
8
0.600
Why?
RNA, Viral
3
2015
18
0.590
Why?
Pharynx
3
2020
7
0.590
Why?
Mycoplasma
1
2015
2
0.590
Why?
Mycoplasma Infections
1
2015
2
0.590
Why?
Antigens, Bacterial
3
2011
9
0.580
Why?
Bordetella pertussis
1
2014
1
0.570
Why?
Kansas
3
2022
47
0.570
Why?
Spike Glycoprotein, Coronavirus
4
2022
19
0.570
Why?
Chromatography, Affinity
1
2014
3
0.570
Why?
Macrolides
5
2020
7
0.550
Why?
Blood Specimen Collection
2
2011
4
0.550
Why?
Adenovirus Infections, Human
2
2011
3
0.540
Why?
Vancomycin
1
2014
17
0.540
Why?
Virus Cultivation
4
2015
4
0.530
Why?
Animals
12
2022
869
0.530
Why?
Candida
2
2003
3
0.520
Why?
Case-Control Studies
7
2022
124
0.490
Why?
Enterococcus
1
2012
3
0.480
Why?
Seasons
5
2022
15
0.480
Why?
Gram-Positive Bacterial Infections
1
2012
8
0.480
Why?
Risk Factors
7
2020
403
0.480
Why?
Paramyxoviridae
1
2011
1
0.480
Why?
Streptococcus bovis
1
2011
1
0.470
Why?
Paramyxoviridae Infections
1
2011
10
0.470
Why?
Meningitis, Bacterial
1
2011
6
0.470
Why?
Oligonucleotide Probes
2
2009
8
0.460
Why?
Campylobacter Infections
1
2011
2
0.460
Why?
False Positive Reactions
1
2011
5
0.460
Why?
Adenoviruses, Human
1
2011
1
0.450
Why?
Intensive Care Units, Pediatric
1
2011
7
0.450
Why?
Blood
1
2011
13
0.450
Why?
Viral Vaccines
1
2011
3
0.440
Why?
Catheterization, Peripheral
1
2011
6
0.440
Why?
Meningitis, Viral
2
2022
2
0.430
Why?
Follow-Up Studies
5
2021
314
0.430
Why?
Vaccination
5
2022
34
0.420
Why?
Pediatric Nursing
1
2010
4
0.420
Why?
Infection Control
1
2010
7
0.420
Why?
Genotyping Techniques
2
2020
18
0.410
Why?
Pyelonephritis
4
2004
5
0.400
Why?
Epidemiological Monitoring
5
2021
6
0.390
Why?
Encephalitis, Viral
1
2009
1
0.390
Why?
Simplexvirus
1
2009
2
0.390
Why?
Haemophilus influenzae
1
2009
3
0.390
Why?
Antifungal Agents
2
2020
13
0.380
Why?
Mycobacterium
2
2010
2
0.380
Why?
Streptococcus pneumoniae
1
2009
16
0.380
Why?
Enterobacteriaceae Infections
2
2018
8
0.370
Why?
Predictive Value of Tests
4
2019
101
0.350
Why?
Adhesins, Bacterial
2
2004
2
0.340
Why?
Reproducibility of Results
3
2012
183
0.340
Why?
Influenza A Virus, H3N2 Subtype
3
2021
4
0.330
Why?
beta-Lactamases
3
2018
6
0.330
Why?
Candida albicans
2
2003
4
0.320
Why?
Fucosyltransferases
2
2015
2
0.300
Why?
Algorithms
3
2020
95
0.300
Why?
Cluster Analysis
4
2015
30
0.290
Why?
Immunization Programs
2
2019
6
0.290
Why?
Cross Infection
2
2017
13
0.290
Why?
Collagen Type IV
1
2004
2
0.290
Why?
Escherichia coli Proteins
1
2004
2
0.290
Why?
Fimbriae, Bacterial
4
2001
4
0.280
Why?
Genetic Variation
2
2015
143
0.280
Why?
Cephalosporin Resistance
3
2018
4
0.280
Why?
Saliva
2
2021
9
0.270
Why?
Pandemics
2
2021
49
0.270
Why?
Longitudinal Studies
2
2020
123
0.260
Why?
Cohort Studies
3
2021
259
0.260
Why?
Acute Disease
2
2020
65
0.250
Why?
DNA Probes
1
2002
3
0.250
Why?
Fluorescent Dyes
1
2002
7
0.250
Why?
Oseltamivir
2
2021
6
0.250
Why?
Seroepidemiologic Studies
2
2019
3
0.240
Why?
Craniocerebral Trauma
1
2022
20
0.240
Why?
Midwestern United States
2
2013
42
0.240
Why?
Critical Care
3
2018
13
0.240
Why?
Child, Hospitalized
3
2022
29
0.240
Why?
Hospitals, Pediatric
3
2020
183
0.230
Why?
Vaccines
1
2021
13
0.230
Why?
Herpesvirus 1, Cercopithecine
1
2021
1
0.230
Why?
Central Nervous System
1
2021
6
0.230
Why?
Nasal Mucosa
1
2021
8
0.230
Why?
Immunity, Humoral
1
2021
6
0.230
Why?
Cloud Computing
1
2021
5
0.230
Why?
Child Abuse
1
2022
53
0.230
Why?
Risk Assessment
2
2020
138
0.230
Why?
Lung Diseases
1
2021
40
0.230
Why?
Disease Management
2
2018
38
0.220
Why?
Lymphadenitis
2
2013
3
0.220
Why?
Public Health Surveillance
1
2020
4
0.220
Why?
Klebsiella Infections
2
2017
3
0.220
Why?
ROC Curve
1
2020
19
0.220
Why?
Ambulatory Care Facilities
1
2021
30
0.220
Why?
Quebec
1
2020
4
0.210
Why?
Herpesvirus 1, Human
1
2020
2
0.210
Why?
Drug Resistance, Viral
1
2020
3
0.210
Why?
Guanine Nucleotide Exchange Factors
1
2020
3
0.210
Why?
Coronavirus Infections
1
2020
15
0.210
Why?
DNA, Bacterial
3
2011
5
0.210
Why?
Pneumonia, Viral
1
2020
16
0.210
Why?
Mouth
1
2020
3
0.210
Why?
Canada
1
2020
33
0.210
Why?
International Classification of Diseases
1
2020
8
0.210
Why?
Family Health
1
2020
14
0.210
Why?
Gastrointestinal Diseases
1
2021
52
0.210
Why?
Monitoring, Physiologic
1
2020
23
0.210
Why?
Europe
1
2020
30
0.210
Why?
Postoperative Care
1
2020
29
0.210
Why?
Early Diagnosis
1
2020
35
0.210
Why?
Immunoenzyme Techniques
1
2019
12
0.200
Why?
Age Distribution
1
2019
37
0.200
Why?
Prognosis
1
2020
180
0.200
Why?
Gonorrhea
2
2015
5
0.200
Why?
Molecular Epidemiology
3
2017
6
0.200
Why?
History, 21st Century
1
2019
6
0.200
Why?
Chronic Disease
3
2012
101
0.190
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2019
3
0.190
Why?
Bacterial Typing Techniques
2
2016
4
0.190
Why?
Immunization Schedule
1
2019
7
0.190
Why?
Critical Pathways
1
2018
10
0.190
Why?
Hematologic Diseases
1
2018
4
0.190
Why?
Immunologic Deficiency Syndromes
1
2018
9
0.190
Why?
False Negative Reactions
1
2018
12
0.180
Why?
Intestines
1
2018
27
0.180
Why?
Cytopathogenic Effect, Viral
1
2017
2
0.180
Why?
Sapovirus
1
2017
1
0.180
Why?
Cell Line
1
2017
104
0.170
Why?
Cells, Cultured
1
2017
112
0.170
Why?
Klebsiella pneumoniae
1
2017
2
0.170
Why?
Dose-Response Relationship, Drug
1
2017
99
0.170
Why?
Genetic Predisposition to Disease
2
2015
146
0.170
Why?
Antibiotic Prophylaxis
1
2017
30
0.170
Why?
Practice Guidelines as Topic
1
2017
98
0.170
Why?
Staphylococcal Skin Infections
1
2016
3
0.170
Why?
Neoplasms
1
2018
93
0.170
Why?
Clindamycin
1
2016
3
0.160
Why?
Length of Stay
2
2018
225
0.160
Why?
Recombination, Genetic
1
2015
4
0.160
Why?
Virulence Factors
1
2015
4
0.160
Why?
C-Reactive Protein
1
2015
13
0.160
Why?
Hemoglobins
1
2015
24
0.150
Why?
Chlamydia trachomatis
1
2015
3
0.150
Why?
Trichomonas Vaginitis
1
2015
3
0.150
Why?
Chlamydia Infections
1
2015
4
0.150
Why?
Equipment Failure
1
2015
8
0.150
Why?
Dogs
1
2015
18
0.150
Why?
DNA, Ribosomal
2
2011
3
0.140
Why?
RNA, Ribosomal, 16S
2
2011
7
0.140
Why?
Unnecessary Procedures
1
2015
16
0.140
Why?
Treatment Outcome
5
2018
618
0.140
Why?
Quality Improvement
1
2015
64
0.140
Why?
HeLa Cells
6
2004
21
0.140
Why?
Base Sequence
2
2004
114
0.130
Why?
Age Factors
3
2021
225
0.130
Why?
Molecular Sequence Data
3
2015
117
0.130
Why?
DNA, Fungal
2
2003
5
0.130
Why?
Tertiary Care Centers
1
2013
8
0.130
Why?
Viral Proteins
1
2013
14
0.130
Why?
Abscess
1
2013
12
0.130
Why?
Incidence
2
2011
132
0.130
Why?
Diarrhea
2
2011
16
0.130
Why?
Mice
3
2022
432
0.130
Why?
Anti-Infective Agents
1
2013
17
0.130
Why?
Vaccines, Attenuated
3
2019
6
0.120
Why?
Pneumococcal Infections
2
2011
16
0.120
Why?
Costs and Cost Analysis
1
2012
8
0.120
Why?
Epitopes
2
2022
19
0.120
Why?
Enterotoxins
1
2011
2
0.120
Why?
Middle Ear Ventilation
1
2011
1
0.120
Why?
Exudates and Transudates
1
2011
2
0.120
Why?
Operon
3
2001
4
0.120
Why?
Communicable Diseases
1
2011
5
0.120
Why?
Campylobacter
1
2011
2
0.110
Why?
Restriction Mapping
1
2011
14
0.110
Why?
Serotyping
1
2011
6
0.110
Why?
Epidemiologic Methods
1
2011
3
0.110
Why?
Policy Making
1
2011
3
0.110
Why?
Immunocompromised Host
2
2020
9
0.110
Why?
Cost of Illness
2
2020
14
0.110
Why?
Quality of Health Care
1
2010
18
0.100
Why?
Linear Models
1
2010
58
0.100
Why?
Postoperative Complications
1
2011
170
0.100
Why?
Cross-Sectional Studies
3
2019
275
0.100
Why?
Disease Models, Animal
3
2005
79
0.100
Why?
Databases, Factual
1
2010
107
0.100
Why?
Moraxellaceae Infections
1
2009
1
0.100
Why?
Parents
2
2021
132
0.100
Why?
Haemophilus Infections
1
2009
4
0.100
Why?
Bacterial Proteins
3
2017
8
0.100
Why?
Chromatography, High Pressure Liquid
2
2010
43
0.090
Why?
Mycobacterium avium-intracellulare Infection
1
2008
2
0.090
Why?
Mutation
3
2019
198
0.090
Why?
Biomarkers
2
2021
120
0.090
Why?
DNA, Ribosomal Spacer
2
2010
3
0.090
Why?
Temperature
2
2010
11
0.090
Why?
Adenoviridae
1
2007
4
0.090
Why?
Virulence
2
2004
6
0.090
Why?
Mycobacterium Infections
1
2006
2
0.080
Why?
Mice, Inbred C3H
2
2004
10
0.080
Why?
Anemia, Sickle Cell
1
2006
21
0.080
Why?
Illinois
2
2015
5
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2015
25
0.070
Why?
Pregnancy Complications, Infectious
2
2001
27
0.070
Why?
Chromatography, Gas
1
2004
1
0.070
Why?
Fatty Acids
1
2004
4
0.070
Why?
Culture Media
1
2003
1
0.070
Why?
Candida glabrata
1
2003
1
0.070
Why?
Mycology
1
2003
2
0.070
Why?
Gene Amplification
1
2003
6
0.070
Why?
CHO Cells
2
2002
4
0.070
Why?
Cricetinae
2
2002
7
0.070
Why?
DNA Primers
1
2003
41
0.070
Why?
Kidney
1
2004
88
0.070
Why?
Phenotype
1
2004
217
0.060
Why?
Mycological Typing Techniques
1
2002
3
0.060
Why?
Candidiasis
1
2002
5
0.060
Why?
Complement System Proteins
1
2002
3
0.060
Why?
Macaca nemestrina
1
2002
1
0.060
Why?
Trypanosoma cruzi
1
2002
2
0.060
Why?
Chagas Disease
1
2002
2
0.060
Why?
Hematoma, Subdural
1
2022
5
0.060
Why?
Microbiological Techniques
2
2015
5
0.060
Why?
Hospitals
1
2022
35
0.060
Why?
Immunity, Cellular
1
2021
9
0.060
Why?
Viral Load
1
2021
19
0.060
Why?
Epitope Mapping
1
2021
7
0.060
Why?
Antibody Specificity
1
2021
9
0.060
Why?
Cross Reactions
1
2021
7
0.060
Why?
Immunity, Innate
1
2021
17
0.060
Why?
Receptors, Cell Surface
1
2001
15
0.060
Why?
Host-Pathogen Interactions
1
2021
8
0.060
Why?
T-Lymphocytes
1
2021
33
0.060
Why?
Transcriptome
1
2021
32
0.060
Why?
Viruses
1
2021
2
0.060
Why?
Phosphoproteins
1
2021
17
0.060
Why?
Vaccine Potency
1
2021
7
0.060
Why?
Microtubules
2
1999
6
0.060
Why?
Bacteria
1
2021
9
0.060
Why?
Immunization
1
2021
21
0.060
Why?
Comorbidity
1
2021
66
0.060
Why?
Immunoglobulin G
1
2021
34
0.060
Why?
Neck
2
2013
4
0.060
Why?
Pregnancy
4
2005
251
0.060
Why?
Dialysis Solutions
1
2021
19
0.060
Why?
Catheters, Indwelling
1
2021
27
0.060
Why?
Self Care
1
2021
23
0.050
Why?
Catheterization
1
2021
25
0.050
Why?
RNA, Messenger
1
2021
178
0.050
Why?
Skin
1
2020
14
0.050
Why?
Family Characteristics
1
2020
9
0.050
Why?
Vacuoles
1
2000
1
0.050
Why?
Glycosylphosphatidylinositols
1
2000
1
0.050
Why?
Interviews as Topic
1
2020
37
0.050
Why?
RNA, Ribosomal, 23S
1
2019
1
0.050
Why?
Liver
1
2021
155
0.050
Why?
Cytoskeleton
1
1999
3
0.050
Why?
Infectious Disease Transmission, Vertical
1
1999
25
0.050
Why?
Medically Uninsured
1
2019
6
0.050
Why?
Australia
1
2019
8
0.050
Why?
Netherlands
1
2019
5
0.050
Why?
Premature Birth
1
2019
6
0.050
Why?
Polymorphism, Single Nucleotide
1
2020
205
0.050
Why?
Regression Analysis
1
2018
59
0.050
Why?
Metabolic Diseases
1
2018
13
0.050
Why?
Practice Patterns, Nurses'
1
2017
5
0.040
Why?
Bacterial Outer Membrane Proteins
1
2017
1
0.040
Why?
beta-Lactam Resistance
1
2017
1
0.040
Why?
Fimbriae Proteins
1
2017
1
0.040
Why?
Penicillin-Binding Proteins
1
2016
2
0.040
Why?
Pharmacy Service, Hospital
1
2016
8
0.040
Why?
Practice Patterns, Physicians'
1
2017
86
0.040
Why?
Sequence Homology
1
2015
2
0.040
Why?
Evolution, Molecular
1
2015
3
0.040
Why?
Genome, Viral
1
2015
4
0.040
Why?
China
1
2015
9
0.040
Why?
Dyspnea
1
2015
5
0.040
Why?
Colorado
1
2015
9
0.040
Why?
Respiratory Sounds
1
2015
9
0.040
Why?
Cough
1
2015
7
0.040
Why?
Respiration, Artificial
1
2015
31
0.040
Why?
Emergency Medical Services
1
2015
18
0.040
Why?
Primary Health Care
1
2015
43
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2015
80
0.040
Why?
Clinical Laboratory Services
1
2015
2
0.040
Why?
Economics, Hospital
1
2015
3
0.040
Why?
Sexually Transmitted Diseases
1
2015
10
0.040
Why?
Cost Savings
1
2015
10
0.040
Why?
Gene Frequency
1
2015
75
0.040
Why?
Program Evaluation
1
2015
50
0.040
Why?
Sexual Behavior
1
2015
38
0.040
Why?
Asthma
1
2015
135
0.030
Why?
Drainage
1
2013
39
0.030
Why?
Rats, Sprague-Dawley
2
2005
97
0.030
Why?
Ambulatory Care
1
2013
41
0.030
Why?
Rats
2
2005
207
0.030
Why?
Diagnostic Test Approval
1
2011
1
0.030
Why?
Tympanic Membrane
1
2011
1
0.030
Why?
Prosthesis Failure
1
2011
2
0.030
Why?
Administration, Topical
1
2011
6
0.030
Why?
United States Food and Drug Administration
1
2011
7
0.030
Why?
Otitis Media with Effusion
1
2011
2
0.030
Why?
Administration, Oral
1
2011
65
0.030
Why?
Recurrence
1
2011
104
0.030
Why?
Cell Wall
1
2010
1
0.030
Why?
Mycolic Acids
1
2010
1
0.030
Why?
Pigments, Biological
1
2010
1
0.030
Why?
Chaperonin 60
1
2010
1
0.030
Why?
Enzyme Stability
1
2010
3
0.030
Why?
DNA-Directed RNA Polymerases
1
2010
2
0.030
Why?
Africa
1
2010
2
0.030
Why?
Enzymes
1
2010
5
0.030
Why?
Hot Temperature
1
2010
4
0.030
Why?
Binding Sites
2
2002
50
0.030
Why?
Bacterial Adhesion
2
1999
2
0.020
Why?
Face
1
2008
2
0.020
Why?
Cefoxitin
1
2006
2
0.020
Why?
Doxycycline
1
2006
2
0.020
Why?
Linezolid
1
2006
3
0.020
Why?
Ciprofloxacin
1
2006
4
0.020
Why?
Acetamides
1
2006
3
0.020
Why?
Oxazolidinones
1
2006
3
0.020
Why?
Hydroxyurea
1
2006
3
0.020
Why?
Clarithromycin
1
2006
4
0.020
Why?
Mycobacterium fortuitum
1
2006
3
0.020
Why?
Amikacin
1
2006
4
0.020
Why?
Drug Therapy, Combination
1
2006
43
0.020
Why?
Uterine Diseases
1
2005
1
0.020
Why?
Gene Expression Regulation, Bacterial
1
2005
1
0.020
Why?
Structure-Activity Relationship
1
2002
16
0.020
Why?
Models, Molecular
1
2002
17
0.020
Why?
Mutagenesis, Site-Directed
1
2002
18
0.020
Why?
Protein Structure, Tertiary
1
2002
15
0.020
Why?
DNA, Kinetoplast
1
2002
1
0.020
Why?
Antibodies
1
2002
15
0.020
Why?
Antibodies, Protozoan
1
2002
3
0.020
Why?
Repetitive Sequences, Nucleic Acid
1
2002
9
0.020
Why?
Protein Binding
1
2002
46
0.020
Why?
B-Lymphocytes
1
2002
18
0.020
Why?
Gene Expression
1
2002
72
0.020
Why?
Blood Group Antigens
1
2001
2
0.010
Why?
Oligonucleotides
1
2001
6
0.010
Why?
Intestinal Diseases
1
2001
5
0.010
Why?
Hemagglutinins
1
2001
1
0.010
Why?
Terminology as Topic
1
2001
14
0.010
Why?
Neisseria gonorrhoeae
1
1999
1
0.010
Why?
Complement C1q
1
1999
3
0.010
Why?
Cattle
1
1999
24
0.010
Why?
Actins
1
1999
5
0.010
Why?
Recombinant Proteins
1
1999
65
0.010
Why?
Cytochalasin D
1
1997
1
0.010
Why?
Nocodazole
1
1997
1
0.010
Why?
Microscopy, Electron
1
1997
7
0.010
Why?
Immunohistochemistry
1
1997
68
0.010
Why?
Selvarangan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Physical Neighbors Expand Description
_